PCRX

Pacira BioSciences, Inc.

30.03 USD
+0.34 (+1.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pacira BioSciences, Inc. stock is up 15.28% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 13 May’s closed higher than April. In the last 6 Unusual Options Trades, there were 3 PUTs, 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Apr 14:31 16 Aug, 2024 25.00 PUT 130 1234
22 Apr 18:04 16 Aug, 2024 35.00 CALL 1229 1257
23 Apr 13:57 16 Aug, 2024 25.00 PUT 80 1732
08 May 17:47 16 Aug, 2024 35.00 CALL 400 37
08 May 18:30 21 Jun, 2024 30.00 CALL 500 16
13 May 19:52 16 Aug, 2024 30.00 PUT 144 0

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectionable suspension. iovera system produces controlled doses of cold temperature only to targeted nerves.

  • HC Wainwright & Co.
    Wed May 8, 15:23
    buy
    confirm
  • Barclays
    Wed May 8, 14:10
    buy
    confirm
  • Needham
    Wed May 8, 06:37
    buy
    confirm